Association of the miR-146aC>G, 149C>T, 196a2C>T, and 499A>G polymorphisms with colorectal cancer in the Korean population

Molecular Carcinogenesis

Volumn 51, Issue SUPPL. 1, 2012, Pages

  Min, Kyung Tae ^a   Kim, Jong Woo ^a   Jeon, Young Joo ^a   Jang, Moon Ju ^a   Chong, So Young ^a   Oh, Doyeun ^a   Kim, Nam Keun ^a  

^a CHA University   (South Korea)

Author keywords

Colorectal cancer; MicroRNA; Polymorphism

Indexed keywords

MICRORNA; MICRORNA 146A; MICRORNA 149; MICRORNA 196A2; MICRORNA 499; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RANDOM ALLOCATION;

EID: 84867142644     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21849     Document Type: Article

References (49)

1. National Cancer Information Center. Cancer incidence. http://www.cancer.go.kr/cms/statics/incidence/index.html.
2. Sung JJ, Lau Jy, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asia: Implications for screening. Lancet Oncol 2005; 6: 871-876.
3. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136: 215-233.
4. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-773.
5. Cuellar TL, McManus MT. MicroRNAs and endocrine biology. J Endocrinol 2005; 187: 327-332.
6. Wilfred BR, Wang WX, Nelson PT. Energizing miRNA research: A review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab 2007; 91: 209-217.
7. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res 2004; 14: 1902-1910.
8. Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23: 4051-4060.
9. Gregory RI, Chendrimada TP, Shiekhattar R. MicroRNA biogenesis: Isolation and characterization of the microprocessor complex. Methods Mol Biol 2006; 342: 33-47.
10. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation microRNA genes miR 15 and miR 16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-15529.
11. Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 microRNA in human lung cancers in association with shortened postoperative survival. Cancer Res 2005; 64: 3753-3756.
12. Johnson SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 miRNA family. Cell 2005; 120: 635-647.
13. Eis PS, Tam W, Sun L, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 2005; 103: 3627-3632.
14. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A. High expression of precursor microRNA-155-BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 2004; 39: 67-69.
15. Irio MV, Ferracin M, Liu CG, et al. microRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065-7070.
16. Michael MZ, O' Connor SM, Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003; 1: 882-891.
17. Hu Z, Chen J, Tian T, et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 2008; 118: 2600-2608.
18. Yazici H, Zipprich J, Peng T, et al. Investigation of the miR16-1(C>T)+7 substitution in seven different types of cancer from three ethnic groups. J Oncol 2009; 2009: 827532.
19. Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature-miR-125a alters the processing of pri-miRNA. Hum Mol Genet 2007; 16: 1124-1131.
20. Tian T, Shu Y, Chen J, et al. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev 2009; 18: 1183-1187.
21. Xu J, Hu Z, Xu Z, et al. Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. Hum Mutat 2009; 30: 1231-1236.
22. Hu Z, Liang J, Wang Z, et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 2009; 30: 79-84.
23. Qi P, Dou TH, Geng L, et al. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol 2010; 71: 621-626.
24. Peng S, Kung Z, Sheng C, Zhang Y, Zum H, Cheng Q. Association of microRNA-196a2 gene polymorphism with gastric cancer risk in a Chinese population. Dig Dis Sci 2009; 55: 2288-2293.
25. Guo H, Wang K, Xiong G, et al. A functional variant in microRNA-146a is associated with risk of esophageal squamous cell carcinoma in Chinese Han. Familial Cancer 2010; 9: 599-603.
26. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: A review. Am J Clin Nutr 2007; 86: s836-s842.
27. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J Natl Cancer Inst 2004; 96: 434-442.
28. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Royal Stat Soc Ser B 1995; 57: 289-300.
29. Suzuki Y, Kim HW, Ashraf M, Haider HKh. Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas. Am J Physiol Heart Circ Physiol 2010; 299: H1077-H1082.
30. Zhong H, Wang HR, Yang S, et al. Targeting Smad4 links microRNA-146a to the TGF-beta pathway during retinoid acid induction in acute promyelocytic leukemia cell line. Int J Hematol 2010; 92: 129-135.
31. Avery S, Zafarana G, Gokhale PJ, Andrews PW. The role of SMAD4 in human embryonic stem cell self-renewal and stem cell fate. Stem Cells 2010; 28: 863-873.
32. Moustakas A, Kardassis D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci USA 1998; 95: 6733-6738.
33. Lin RJ, Lin YC, Yu AL. miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells. Mol Carcinog 2010; 49: 719-727.
34. Kawasaki H, Taira K. MicroRNA-196 inhibits HOXB8 expression in myeloid differentiation of HL60 cells. Nucleic Acids Symp Ser (Oxf) 2004; 48: 211-212.
35. Fujino T, Yamazaki Y, Largaespada DA, et al. Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes. Exp Hematol 2001; 29: 856-863.
36. Hornstein E, Mansfield JH, Yekta S, et al. The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development. Nature 2005; 438: 671-674.
37. Sluijter JP, van Mil A, van Vliet P, et al. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol 2010; 30: 859-868.
38. Murakami A, Ishida S, Thurlow J, Revest JM, Dickson C. SOX6 binds CtBP2 to repress transcription from the Fgf-3 promoter. Nucleic Acids Res 2001; 29: 3347-3355.
39. Jakobovits A, Shackleford GM, Varmus HE, Martin GR. Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2, are independently regulated during mouse development. Proc Natl Acad Sci USA 1986; 83: 7806-7810.
40. Srivatsan ES, Misra BC, Venugopalan M, Wilczynski SP. Loss of heterozygosity for alleles on chromosome II in cervical carcinoma. Am J Hum Genet 1991; 49: 868-877.
41. Naidu R, Wahab NA, Yadav M, Kutty MK, Nair S. Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction. Int J Mol Med 2001; 8: 193-198.
42. Hoffman AE, Zheng T, Yi C, et al. microRNA miR-196a-2 and breast cancer: A genetic and epigenetic association study and functional analysis. Cancer Res 2009; 69: 5970-5977.
43. Chen H, Sun LY, Chen LL, Zheng HQ, Zhang QF. A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer Chinese. Intern Med J, in press.
44. Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004; 304: 594-596.
45. Wynter CV. The dialectics of cancer: A theory of the initiation and development of cancer through errors in RNAi. Med Hypotheses 2006; 66: 612-635.
46. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, Chapelle ADL. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 2008; 105: 7269-7274.
47. Xu T, Zhu Y, Wei QK, et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 2008; 29: 2126-2131.
48. Xu B, Feng NH, Li PC, et al. A functional polymorphism in pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate 2010; 70: 467-472.
49. Schimanski CC, Frerichs K, Rahman F, et al. High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol 2009; 15: 2089-2096.